Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com

by · The Cerbat Gem

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research note released on Friday morning. The brokerage issued a hold rating on the stock.

Separately, Benchmark reaffirmed a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Get Our Latest Analysis on Milestone Scientific

Milestone Scientific Trading Up 16.0 %

Milestone Scientific stock opened at $0.93 on Friday. The stock has a market cap of $72.05 million, a P/E ratio of -13.21 and a beta of 1.10. The company has a 50-day moving average price of $0.81 and a 200 day moving average price of $0.86. Milestone Scientific has a 12-month low of $0.52 and a 12-month high of $1.10.

Insider Activity

In related news, Director Leonard Osser sold 107,984 shares of the business’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the sale, the director now owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. The trade was a 2.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last three months, insiders have sold 128,193 shares of company stock valued at $116,234. Company insiders own 24.75% of the company’s stock.

Hedge Funds Weigh In On Milestone Scientific

Institutional investors have recently bought and sold shares of the company. World Investment Advisors LLC acquired a new stake in shares of Milestone Scientific during the third quarter worth about $91,000. Y Intercept Hong Kong Ltd purchased a new stake in Milestone Scientific during the 3rd quarter worth approximately $48,000. Finally, Geode Capital Management LLC increased its stake in Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares during the period. 5.79% of the stock is owned by institutional investors and hedge funds.

About Milestone Scientific

(Get Free Report)

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

Further Reading